The Federal Anti-Kickback Statute (the “AKS”) prohibits the payment or receipt of remuneration to induce or reward referrals of items or services reimbursable by a federal health care program (including, but not limited to, Medicare and... Read More
In part one of this article series, Frier Levitt dissected the May 9, 2022, Centers for Medicare and Medicaid Services (CMS) Final Rule (Final Rule) entitled, “Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare... Read More
Two practices in Connecticut recently settled large six-figure lawsuits with federal and state agencies resolving allegations of improperly employing an individual who was excluded from all federal healthcare programs. In both instances, the... Read More
Recent CMS agency rulemaking has essentially eliminated pharmacy Direct and Indirect Remuneration (DIR) fees beginning in Plan Year 2024. Providers “in the know,” however, are not cheering. Our more technical article on the rulemaking is... Read More
On December 27, 2020, Congress enacted, and the President signed, H.R. 3630, the Surprise Act (“Act”), which will take effect on January 1, 2022. This Act expands restrictions on charging health care plan holders out-of-network rates for certain... Read More
Frier Levitt Podiatrist-Attorney Lawrence Kobak, DPM, JD shares a must read Medical-Legal Checklist for 2021 in the latest issue of Podiatry Management. He encourages practitioners to start the year off right by reviewing things such as office... Read More
On December 9th, a four-judge panel in the Appellate Court in New York's Second Department unanimously ruled that the MLMIC Buyout Proceeds from the sale and demutualization of the State's largest medical malpractice insurer, the Medical Liability... Read More
In today’s New York Law Journal, Frier Levitt attorney Joel M. Greenberg, Esq. discusses two recent appellate decisions that determined that the proceeds from the sale and demutualization of New York’s largest medical malpractice carrier, the... Read More
COVID-19 is producing mixed results for health insurance companies and their bottom line. Amongst the worst performers in 2020 is Horizon Blue Cross Blue Shield of New Jersey (“Horizon”). According to a recent report by Modern Healthcare,... Read More
